Professional Documents
Culture Documents
CTG Reporting
CTG Reporting
CARDIOTOCOGRAPHY
PGI ALIMBOYOGUEN, REXOR
OBJECTIVES
• TO BE ABLE TO KNOW AND UNDERSTAND THE
FUNCTION AND MECHANISM OF THE
CARDIOTOCOGRAM
CONTINUOUS:
• ELECTRONIC FETAL MONITORING
⚬ DIRECT INTERNAL MONITORING
⚬ INDIRECT EXTERNAL MONITORING
CONTINUOUS INDIRECT
CONTINUOUS EXTERNAL
DIRECT INTERNAL MONITORING
MONITORING
EPIDURAL ANALGESIA
ABNORMALITIES DURING
INTERMITTENT FETAL
AUSCULTATION
INDUCED OR AUGMENTED LABOR
TRACING ACQUISITIONS
• MATERNAL POSITION FOR CTG
• PAPER SCALES FOR CTG MONITORING AND VIEWING
• EXTERNAL VERSUS INTERNAL FHR MONITORING
• EXTERNAL VERSUS INTERNAL MONITORING OF UTERINE CONTRACTIONS
• SIMULTANEOUS MONITORING OF THE MATERNAL HEART RATE
• MONITORING OF TWINS
• STORAGE OF TRACINGS
ANALYSIS OF TRACINGS:
FEATURES OF CTG TRACING
• BASELINE FETAL HEART RATE
• VARIABILITY
• ACCELERATIONS
• DECELERATIONS
• CONTRACTIONS
BASELINE FETAL HEART RATE
Mean Fetal Heart Rate is rounded to
Baseline must be for a minimum of 2
increments of 5 bpm during a 10 minute
minutes in any 10 minute segment
segment excluding segments that differ
by >25 bpm
Head compression
MATERNAL FEVER (MOST COMMON) Congenital heart block
Fetal compromise Fetal hypoxia
Cardiac arrhythmias Maternal hypothermia
Maternal administration of
parasympathetic inhibiting
(Atropine) or sympathomimetic
(Terbutaline) drugs
BASELINE FETAL HEART RATE
BASELINE FHR
CONTRACTIONS
BASELINE FETAL HEART RATE
VARIABILITY
• Important index of cardiovascular function
• Reflects a sympathetic and parasympathetic push
and pull mediated by fetal SA node
• Fluctuations with irregular amplitude and
inconstant frequency
• Normal variability shows oscillations that change to
6 to 25 bpm for >2 cycles/min
VARIABILITY
CAUSES OF DECREASED OR ABSENT VARIABILITY:
- Fetal acidemia (baby is hypoxic), maternal acidemia
- Fetal asleep
- Prematurity
- Drugs (MgSO4 – for patients with pre eclampsia and
eclampsia; diazepam; meperidine)
- Vagal blockade (atropine)
- Defective cardiac conduction system
CRITERIA FOR QUANTIFICATION OF VARIABILITY
• Fetal intracranial
hemorrhage
• Severe fetal asphyxia
• Severe fetal anemia
• Chorioamnionitis
• Fetal distress
• Umbilical cord occlusion
ACCELERATIONS
>32 weeks AOG:
• Acceleration is ≥15 bpm above the baseline Abrupt FHR increase above the baseline with the
and the acceleration lasts ≥15 seconds or time from onset of the acceleration to its peak within
longer but less than 2 minutes 30 secs
<32
<32 weeks
weeksAOG:
AOG: Change in baseline if the acceleration lasts >10
•• Acceleration
Decelerationis ≥10 bpm above
is ≥10 bpm the baseline
below the minutes
and the acceleration
baseline lasts ≥10 seconds
and the deceleration or
lasts ≥10
longer but less than 2 minutes EARLY, LATE, VARIABLE AND PROLONGED
seconds or longer but less than 2 minutes
DECELERATIONS
DECELERATIONS
EARLY DECELERATION
Seen in active labor Not associated with
between 4 and 7 cm tachycardia, loss of variability
cervical dilation or other FHR changes
C O R D C O M P R E S S I O N PAT T E R N S 🡪
Last between 15 sec and 2 occlusion of vein
min, depth is >15 bpm in 🡪 reduced fetal blood return 🡪
amplitude onset varies with deceleration
successive contractions
VARIABLE DECELERATION
VARIABLE DECELERATION
PROLONGED DECELERATION
FIGO: Pathological
CATEGORY III
CATEGORY III
CONTRACTION STRESS TEST
- Intravenous oxytocin or ni pple
stimulation (rub through clothing for
2 minutes) is both used to stimulate
contractions
- It is a test of uteroplacental
insufficiency
- Requires 90 minutes
• NON REACTIVE:
⚬ < 2 A C C E L E R AT I O N S
⚬ N o fe t a l m o v e m e n t , n o a c c e l e r a t i o n
with movement or
⚬ Stimulation, poor or absent long
term variability in a 20 min period
NON STRESS TEST
MATERNAL POSITIONING
• L AT E R A L R E C U M B E N T
POSITION
• UPRIGHT POSITION
• Tr a d i t i o n a l s u p i n e r e c u m b e n t c a n l e a d t o a o r t o c a v a l c o m p r e s s i o n ,
d e c r e a s e d p l a c e n t a l p e r f u s i o n a n d fe t a l o x y g e n a t i o n
REFERENCES:
• C u n n i n g h a m , F. , e t . a l ( 2 0 2 2 ) . W i l l i a m s O b s t e t r i c s ( 2 6 t h e d . ) . U S A : M c G r a w - H i l l
• FIGO Consensus Guidelines on Intrapartum Fetal Monitoring
• A G R E E M E N T A N D A C C U R A C Y U S I N G F I G O , A C O G A N D N I C E C A R D I OTO C O G R A P H Y
I N T E R P R E TAT I O N G U I D E L I N E S
• P O C K E T G U I D E TO F E TA L M O N I TO R I N G : A M U LT I D I S C I P L I N A R Y A P P R O A C H , 7 T H E D I T I O N
THANK
YOU!